Eliglustat Tartrate
Overview
Eliglustat Tartrate is a glucosylceramide synthase inhibitor used for the long-term treatment of adult patients with Gaucher disease type 1. It works by reducing the amount of glucosylceramide that the body produces, helping to manage the condition.
API suppliers (4)
Suppliers of Eliglustat Tartrate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 2 of 4 suppliers.
3 of 4 hold a GMP certificate on record in the EU or UK registers
- Maithri Laboratories Private LimitedIndia1 active DMF GMP on record
- Hetero Drugs LimitedIndia1 active DMF GMP on record
- BIOPHORE INDIA PHARMACEUTICALS PVT LTD1 active DMF
- DR REDDYS LABORATORIES LTD1 active DMF GMP on record
Therapeutic areas
Do you supply Eliglustat Tartrate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.